While the kinetic profile of ctgf expression in these contexts is unknown, our observations suggest that higher SMAD4 levels may also allow more sustained ctgf transcription activity in the context of fibrosis and tumor metastasis. The gene discussed is CCN2; the disease is neoplasm.